The Parenteral Drug Association (PDA) is the leading global facilitator of science, technology and regulatory information. The PDA creates awareness and understanding of important issues facing the pharmaceutical and biopharmaceutical community and delivers education for the community. Founded in 1946 as a nonprofit organization, PDA is committed to developing scientifically sound, practical technical information and expertise to advance pharmaceutical / biopharmaceutical manufacturing science and regulation so members can better serve patients.
PDA was founded in 1946 as the Parenteral Drug Association by a small group of pharmaceutical manufacturers who recognized the need for an organization to disseminate technical information within the industry. Today, coordinated through its headquarters and its Training & Research Institute in Bethesda, Maryland, PDA volunteers worldwide carry out its mission of promoting the exchange of rapidly evolving information on the latest technology and regulations concerning high-quality pharmaceutical production.
PDA is the recognized authoritative voice and leading technical organization in the field of parenteral science and technology. Through the development of Technical Reports and responses to regulatory initiatives, PDA and its members influence the future course of pharmaceutical products technology.
With more than 10,000 individual members worldwide, PDA draws its strength from the technical expertise of its membership. Conferences, meetings and courses bring together pharmaceutical manufacturers, suppliers, users, academics and regulatory officials to discuss issues of mutual interest. These exchanges of technical knowledge and expertise assist the advancement of pharmaceutical science and technology in the interest of public health.
Check out the PDA Interactive History Book
The History of PDA: 65 Years of Connecting People, Science and Regulation.
This 232-page book provides details on the explosive growth in PDA activities in the 15 years since the Golden Anniversary. Chapters cover the people who make PDA what it is, the scientific activities of the organization, the membership's influence on regulation, the Training and Research Institute, international growth and conferences. Nearly 200 photos and graphics are included. Two 50th Anniversary booklets produced in 1996 are included as appendices.
To maximize product quality, availability, and value by connecting people, science, and regulation within the pharmaceutical and biopharmaceutical community so that PDA is:
- The preferred choice for professionals who seek specialized, innovative skills and knowledge enhancing their professional development
- The premier educational partner for professionals in academia, industry and government for the advancement of manufacturing, quality and regulatory science
- An organization that aligns its practices and resources in support of its core values of science based, integrity, and inclusion
To advance pharmaceutical / biopharmaceutical manufacturing science and regulation so members can better serve patients.
Science Based: Science is the foundation of our organization. We utilize a scientific approach to meet challenges and continuously improve. It is not subjective or emotional, but rather a logical, open, rational and transparent process.
Integrity: We are relentless in applying the highest ethical standards to our products, services and actions. We will never compromise ethics. We will be known for living to the highest forms and standards of ethical behavior. We will honor our commitments.
Inclusion: We work together to create a culture of inclusion built on trust, respect and dignity for all. We contribute to the advancement of pharmaceutical / biopharmaceutical operations by building partnerships with professionals in academia, industry and regulatory bodies to better serve patients.
PDA 2020 Strategic Plan
The PDA Strategic Plan covers the direction PDA has decided to take during the next 4 years until 2020. The plan covers the areas PEOPLE, SCIENCE, REGULATION and LEADERSHIP & MANAGEMENT. For each of these areas the Strategic Planning Committee and the Board of Directors have defined a clear focus on how PDA can best service its membership over the next few years.
We invite you to read the entire Strategic Plan and contact us if you have any questions.
PDA Strategic Plan
PDA Global Headquarters
4350 East West Highway, Suite 150
Bethesda, MD 20814 USA
Tel: +1 (301) 656-5900
Fax: +1 (301) 986-0296
PDA Europe Organization
PDA Europe gemeinnuetzige GmbH was founded in 2006. It is a non-profit organization located in Berlin Tegel. PDA Europe is a subsidiary of Parenteral Drug Association, Inc., an American non-profit corporation.
PDA Europe gGmbH
Am Borsigturm 60
Tel: + 49 (0) 30 43 655 08-0
Fax: + 49 (0) 30 43 655 08-66